Maridebart Cafraglutide
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Amgen · Phase 2 · Active, not recruiting · Enrollment 180
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart Cafraglutide | Obesity or overweight | n/r | 4 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 4 | n/r | n/r |